Chamber and committees

Within the Scottish Government, policy responsibility for Health and Care Research sits with the Chief Scientist Office (CSO).

CSO runs a number of research project and fellowship funding programmes. These are open to applications for research across the clinical spectrum, including mesothelioma. These funding opportunities are well known among the health research community in Scotland.

Response Mode Funding Schemes – Chief Scientist Office

Fellowship Funding – Chief Scientist Office

CSO research project and fellowship funding is awarded following a rigorous independent expert review process. Applications on the diagnosis, treatment and management of mesothelioma from the University of Glasgow and Queen Elizabeth University Hospital are welcomed. Any such applications would go through CSO's standard evaluation process to enable funding decisions to be made.

The Scottish Government is engaging with the Society for Chief Officers of Trading Standards Scotland (SCOTSS),Trading Standards and Police Scotland to assess the effectiveness of current enforcement mechanisms available to Trading Standards in Scotland to tackle the sale of illicit tobacco and vaping products and is considering the closure order mechanisms available to Trading Standards in England and Wales.

The Scottish Government has not had any direct discussions with the Department of Health and Social Care (DHSC) regarding encouraging manufacturers to submit a licensing application for the ACT-O-Vial hydrocortisone system and other similar products, as medicines regulation and licensing are reserved matters.

The decision to market a product in the UK rests with the pharmaceutical company. Neither the MHRA nor the UK or Scottish Governments can compel a pharmaceutical company to seek a marketing authorisation for, or supply, a product in the UK market.

The Solu-Cortef Act-O-Vial® 100 mg/2 mL injection is not licensed in the UK but may be supplied as an unlicensed imported medicine through specialist importers where clinically appropriate. Community pharmacists wishing to obtain this product are required to seek approval from their Health Board before ordering an unlicensed import.

We are focusing care for the smallest and sickest babies in three neonatal intensive care units in Scotland. This decision is based on clear evidence that that the outcomes for these babies, who are born at less than 27 weeks gestation, or who need multiple complex life support interventions or surgery, are improved when they are born and cared for in a unit where that specialist care is concentrated, with a high throughput of cases, and where support services are co-located. The vast majority of sick babies will continue to be cared for in local neonatal units, and these units will continue to provide a level of intensive care. It is important that we continue to move forward with implementation of this change, it is what families would expect us to do.

The Taskforce has met three times. A paper on neonatal priorities was shared at the third meeting, however that paper did not propose reconsideration of the location of neonatal intensive care units in Scotland.

Within the Scottish Government, policy responsibility for Health and Care Research sits with the Chief Scientist Office (CSO).

CSO runs a number of research project and fellowship funding programmes. These are open to applications for research across the clinical spectrum, including mesothelioma. These funding opportunities are well known among the health research community in Scotland. All applications go through a rigorous independent expert review process to enable funding decisions to be made.

Response Mode Funding Schemes – Chief Scientist Office

Fellowship Funding – Chief Scientist Office

There are no current projects or fellowships in Mesothelioma.

In 2018, CSO provided approximately £28K in funding support for a Postdoctoral Clinical Lectureship entitled "Manipulating the immune microenvironment in Malignant Pleural Mesothelioma" - Dr Claire Rooney University of Glasgow.

In addition to directly funding research projects and fellowships, CSO provides research support infrastructure funding to support the delivery of clinical studies in the NHS in Scotland. The NHS Research Scotland Cancer Network is funded by CSO to increase, support and sustain clinical trial activity in cancer care across Scotland. Cancer | NHS Research Scotland | NHS Research Scotland.

The NRS Cancer Network is supporting the delivery of a number of Clinical Trials in Mesothelioma including PREDICT-Meso which is led by Professor Kevin Blyth from the University of Glasgow.

The aim of PREDICT- Meso to understand how mesothelioma develops and to develop new therapies and tools for new human trials. PREDICT-Meso is funded by CRUK (£5M) and currently involves 230 investigators from 130 institutions in 17 countries https://www.predictmeso.com/.

The Scottish Government has not undertaken a feasibility study for a Demolition Levy. The Scottish Government currently has no plans to introduce a Demolition Levy and while the Scottish Government share concerns around carbon emissions from demolition and the preservation of the built environment, the Scottish Government believes the most straight forward response would be for the UK Government to address any VAT imbalances which disincentivise reuse, retrofitting and refurbishment.

The Maternity and Neonatal Taskforce have met three times this year and each of the minutes have been published on gov.scot which details the work discussed. This can be found here Maternity and Neonatal Taskforce - gov.scot.

On June 11 2026 the Cabinet Secretary for Health and Care announced the Independent Review of Maternity Services in Scotland. Professor Christine McCourt, Chair of the Independent Review will begin her work in September.

The high-level principles of the Independent Review were published on 11 June and are available to read here: https://www.gov.scot/publications/maternity-services-independent-review-principles/

We are currently considering the remit of the Maternity and Neonatal Taskforce and how it may lead on current improvement work, including the HIS Inspection findings whilst the independent review of maternity services takes place.

The data collected in March 2025 by SPICe is taken from a request to health boards on estimates of children and young people seeking an assessment. The Scottish Government does not hold data on the number of children and young people on waiting lists.

However, we do know that in recent years there has been an increase in people seeking a neurodevelopmental diagnosis, resulting in pressure across a variety of services.

The Scottish Government approach prioritises providing timely access to support that meets children and young people’s neurodevelopmental support needs rather than diagnosis.

The National Neurodevelopmental Specification, which was published in 2021, aims to ensure that children and young people receive the support and access to services that meet their needs at the earliest opportunity. It is clear that support should not be dependent on a formal diagnostic assessment.

Last year, in partnership with COSLA, we undertook a Review of implementation of the Specification. This helped us understand what is working well and where further action is needed – it highlighted the significant pressures facing services and the need for clearer national direction and practical support to deliver timely, neuro-affirming care across Scotland.

Following the Review, we committed to delivering a programme of work to support health boards and local authorities to deliver the aims of the Specification. Delivery is being supported by a cross-sector Children and Young People’s Neurodevelopment Taskforce, bringing together expertise from health, education, local government and the third sector to ensure a collaborative, whole-systems approach is being taken.

The Scottish Government recognises the importance of supporting children and families where a parent is recovering from substance use and where reunification is in the best interests of the child. Support is available through a range of national and local services, including alcohol and drug treatment and recovery services, family support organisations, and children and family social work services. These services can help parents sustain recovery, strengthen family relationships and address any practical or emotional challenges that may arise during the reunification process.

Through the Children, Young People and Families Early Intervention Fund and Adult Learning and Empowering Communities Fund the Scottish Government is supporting organisations such as Scottish Families Affected by Alcohol and Drugs, Relationships Scotland and The Spark. These organisations deliver services such as family mediation, relationship counselling, and family support, which can help families strengthen relationships and navigate challenges that may arise during recovery and reunification. We also provide funding to Shared Parenting Scotland, who provide advice, assistance and other support to separated parents experiencing difficulties in having contact with their children.

It is up to individual owners to consider how they manage their pets whilst evacuating their home with consideration given on how to keep them safe and secure. We would encourage pet owners to consider what to do with their pets as part of a home escape plan. However, escape should not be delayed in order to locate or evacuate distressed animals. The last known location of your pet can be given to the fire service on arrival who will consider this in their plan.

SFRS provide information on fire safety in the home on their website: Fire Safety in the Home | Scottish Fire and Rescue Service. They also provide information and guidance regarding wildfires: Wildfires | Scottish Fire and Rescue Service as well as advice on making an escape plan: Escape plan | Scottish Fire and Rescue Service.